These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35409851)

  • 41. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Suyagh M; Farah D; Abu Farha R
    Saudi Pharm J; 2015 Apr; 23(2):147-53. PubMed ID: 25972734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital.
    Vural F; Ciftci S; Vural B
    North Clin Istanb; 2014; 1(3):147-152. PubMed ID: 28058321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
    Seid MA; Kasahun AE; Mante BM; Gebremariam SN
    Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital.
    Ergün Y; Ergün TB; Toker E; Ünal E; Akben M
    Int Health; 2019 May; 11(3):177-184. PubMed ID: 30265317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
    Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
    Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan.
    Abu Hammour K; El-Dahiyat F; Abu Farha R
    J Eval Clin Pract; 2017 Jun; 23(3):608-613. PubMed ID: 28090715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
    Katusiime B; Semakula D; Lubinga SJ
    Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The general practitioner's knowledge and attitude towards proton pump inhibitors adverse effects].
    Rudelle K; Laroche ML
    Therapie; 2020; 75(3):253-260. PubMed ID: 31471066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting patient reporting of adverse drug reactions: a systematic review.
    Al Dweik R; Stacey D; Kohen D; Yaya S
    Br J Clin Pharmacol; 2017 Apr; 83(4):875-883. PubMed ID: 27868226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process.
    Sienkiewicz K; Burzyńska M; Rydlewska-Liszkowska I; Sienkiewicz J; Gaszyńska E
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacovigilance knowledge in family paediatricians. A survey study in Italy.
    Pellegrino P; Carnovale C; Cattaneo D; Perrone V; Antoniazzi S; Pozzi M; Napoleone E; Filograna MR; Clementi E; Radice S
    Health Policy; 2013 Nov; 113(1-2):216-20. PubMed ID: 24012386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
    Riordan DO; Kinane M; Walsh KA; Shiely F; Eustace J; Bermingham M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1363-1372. PubMed ID: 32507924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.